Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127067523 | 12706752 | 3 | F | 20160902 | 20160901 | 20160906 | EXP | GB-JNJFOC-20160827589 | JANSSEN | WHELAN J, LE DELEY MC, DIRKSEN U, JUDSON IR, HAWKINS DS, VAN DEN BERG H, ET AL. EFFICACY OF BUSULFAN-MELPHALAN HIGH DOSE CHEMOTHERAPY CONSOLIDATION (BUMEL) IN LOCALIZED HIGH-RISK EWING SARCOMA (ES): RESULTS OF EURO-EWING 99-R2 RANDOMIZED TRIAL (EE99R2LOC). JOURNAL OF CLINICAL ONCOLOGY 2016;34 (15):11001. | 0.00 | Y | 0.00000 | 20160906 | OT | GB | GB |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127067523 | 12706752 | 1 | PS | DOXORUBICIN HYDROCHLORIDE. | DOXORUBICIN HYDROCHLORIDE | 1 | Unknown | U | U | 50718 | LIPOSOME INJECTION | ||||||||
127067523 | 12706752 | 2 | SS | VINCRISTINE | VINCRISTINE | 1 | Unknown | U | 0 | UNSPECIFIED | |||||||||
127067523 | 12706752 | 3 | SS | IFOSFAMIDE. | IFOSFAMIDE | 1 | Unknown | U | 0 | UNSPECIFIED | |||||||||
127067523 | 12706752 | 4 | SS | ETOPOSIDE. | ETOPOSIDE | 1 | Unknown | U | 0 | UNSPECIFIED |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
127067523 | 12706752 | 1 | Ewing's sarcoma |
127067523 | 12706752 | 2 | Ewing's sarcoma |
127067523 | 12706752 | 3 | Ewing's sarcoma |
127067523 | 12706752 | 4 | Ewing's sarcoma |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
127067523 | 12706752 | DE |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
127067523 | 12706752 | Death | |
127067523 | 12706752 | Off label use | |
127067523 | 12706752 | Product use issue |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
no results found |